DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
van Dullemen HM, van Deventer SJ, Hommes DW et al.
Treatment of Crohnʼs disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).
Gastroenterology 1995;
109: 129-135
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.